Moberg Pharma AB (publ) (MOB) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.012x

Based on the latest financial reports, Moberg Pharma AB (publ) (MOB) has a cash flow conversion efficiency ratio of -0.012x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-8.26 Million ≈ $-888.59K USD) by net assets (Skr676.90 Million ≈ $72.85 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Moberg Pharma AB (publ) - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Moberg Pharma AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Moberg Pharma AB (publ) for a breakdown of total debt and financial obligations.

Moberg Pharma AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Moberg Pharma AB (publ) ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Doxa AB ST:DOXA	0.055x
Microcosm Technology Co Ltd TWO:3354	-0.025x
Studio Mir Co. Ltd. KQ:408900	-0.078x
Kilitch Drugs (India) Limited NSE:KILITCH	-0.025x
Harmoney Corp Ltd AU:HMY	0.514x
MODISON LIMITED NSE:MODISONLTD	0.014x
Samho Dev KO:010960	0.011x
Fiducial Office Solutions PA:SACI	0.047x

Annual Cash Flow Conversion Efficiency for Moberg Pharma AB (publ) (2008–2024)

The table below shows the annual cash flow conversion efficiency of Moberg Pharma AB (publ) from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see Moberg Pharma AB (publ) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr686.82 Million ≈ $73.91 Million	Skr-16.47 Million ≈ $-1.77 Million	-0.024x	+55.89%
2023-12-31	Skr610.73 Million ≈ $65.72 Million	Skr-33.20 Million ≈ $-3.57 Million	-0.054x	-72.25%
2022-12-31	Skr533.58 Million ≈ $57.42 Million	Skr-16.84 Million ≈ $-1.81 Million	-0.032x	+10.43%
2021-12-31	Skr434.05 Million ≈ $46.71 Million	Skr-15.30 Million ≈ $-1.65 Million	-0.035x	+53.42%
2020-12-31	Skr395.58 Million ≈ $42.57 Million	Skr-29.93 Million ≈ $-3.22 Million	-0.076x	-302.29%
2019-12-31	Skr105.68 Million ≈ $11.37 Million	Skr3.95 Million ≈ $425.30K	0.037x	-69.94%
2018-12-31	Skr594.02 Million ≈ $63.93 Million	Skr73.89 Million ≈ $7.95 Million	0.124x	+27.68%
2017-12-31	Skr552.41 Million ≈ $59.45 Million	Skr53.82 Million ≈ $5.79 Million	0.097x	+404.98%
2016-12-31	Skr561.62 Million ≈ $60.44 Million	Skr-17.94 Million ≈ $-1.93 Million	-0.032x	-136.69%
2015-12-31	Skr352.82 Million ≈ $37.97 Million	Skr30.72 Million ≈ $3.31 Million	0.087x	+63.63%
2014-12-31	Skr303.75 Million ≈ $32.69 Million	Skr16.16 Million ≈ $1.74 Million	0.053x	+440.35%
2013-12-31	Skr201.49 Million ≈ $21.68 Million	Skr-3.15 Million ≈ $-338.99K	-0.016x	-129.40%
2012-12-31	Skr178.23 Million ≈ $19.18 Million	Skr9.48 Million ≈ $1.02 Million	0.053x	+145.26%
2011-12-31	Skr76.79 Million ≈ $8.26 Million	Skr-9.02 Million ≈ $-970.70K	-0.117x	+99.73%
2010-12-31	Skr687.70K ≈ $74.01K	Skr-30.41 Million ≈ $-3.27 Million	-44.224x	-5189.34%
2009-12-31	Skr30.21 Million ≈ $3.25 Million	Skr-25.26 Million ≈ $-2.72 Million	-0.836x	+63.51%
2008-12-31	Skr15.23 Million ≈ $1.64 Million	Skr-34.89 Million ≈ $-3.75 Million	-2.291x	--

About Moberg Pharma AB (publ)

ST:MOB Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$58.17 Million

Skr540.51 Million SEK

Market Cap Rank

#21302 Global

#387 in Sweden

Share Price

Skr11.50

Change (1 day)

+3.98%

52-Week Range

Skr7.33 - Skr12.40

All Time High

Skr226.13